Purchases and Sales Made in Q4 2024 in Emergent Bio Solutions Inc. (EBS)
This table provides information about the institutional ownership of Emergent Bio Solutions Inc. (EBS) during Q4 2024. The information is specifically focused on institutions that hold shares of Emergent BioSolutions Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-18.3K- 75.29% |
$141K - $219K
|
5.99K
$46.2K
|
|
|
Jan 14, 2025
Q4 2024
|
Sea Crest Wealth Management, LLC
Purchase, NY |
SELL
|
- |
-25K- 21.06% |
$193K - $299K
|
93.7K
$722K
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-40K- 35.56% |
$309K - $479K
|
72.5K
$559K
|
|
|
Jan 31, 2025
Q4 2024
|
Truist Financial Corp
|
SELL
|
- |
-59K- 40.92% |
$456K - $706K
|
85.2K
$657K
|
|
|
Feb 14, 2025
Q4 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-61.6K- 81.42% |
$475K - $737K
|
14.1K
$108K
|
|
|
Feb 14, 2025
Q4 2024
|
Nomura Holdings Inc
Tokyo, M0 |
SELL
|
- |
-63.9K- 24.72% |
$493K - $765K
|
195K
$1.5M
|
|
|
Jan 29, 2025
Q4 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-79.5K- 17.43% |
$614K - $952K
|
377K
$2.9M
|
|
|
Feb 13, 2025
Q4 2024
|
Cetera Investment Advisers
Schaumburg, IL |
SELL
|
- |
-107K- 27.89% |
$828K - $1.28M
|
277K
$2.14M
|
|
|
Feb 14, 2025
Q4 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-132K- 39.97% |
$1.02M - $1.58M
|
198K
$1.53M
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-163K- 77.56% |
$1.26M - $1.95M
|
47.2K
$364K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-197K- 5.8% |
$1.52M - $2.36M
|
3.2M
$24.7M
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-388K- 50.33% |
$3M - $4.65M
|
383K
$2.95M
|
|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-934K- 42.01% |
$7.21M - $11.2M
|
1.29M
$9.95M
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.17M- 46.74% |
$9M - $14M
|
1.33M
$10.2M
|